APO RESEARCH · REPORT
Contract Pharmaceutical Manufacturing
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Product & engineering
Understand the product.
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Selected research
Industry Research
Contract Pharmaceutical Manufacturing Industry Research Report 2026
Market perspective
Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
Global Contract Pharmaceutical Manufacturing key players include Catalent, Thermo Fisher Scientific, Lonza, Boehringer Ingelheim, Fareva, etc. Global top five players hold a share about 10%.
North America is the largest market, with a share about 30%, followed by Europe and China, having a total share about 30 percent.
Read the full market overview
In terms of product, API is the largest segment, with a share about 75%. And in terms of application, the largest application is Large Enterprise, followed by Small Medium Enterprise.
Report Scope
This report quantifies the global Contract Pharmaceutical Manufacturing market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Contract Pharmaceutical Manufacturing.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Contract Pharmaceutical Manufacturing Market by Company
Catalent
DPx
Lonza
Piramal Healthcare
Aenova
Jubilant
Famar
Boehringer Ingelheim
Fareva Holding
AbbVie
Nipro Corp
Vetter
Sopharma
DPT Laboratories
Recipharm
NextPharma
Dishman
Aesica
Contract Pharmaceutical Manufacturing Segment by Type
Oral
Injectable
API
Other
Contract Pharmaceutical Manufacturing Segment by Application
Large Enterprise
Small Medium Enterprise
Contract Pharmaceutical Manufacturing Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Contract Pharmaceutical Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Contract Pharmaceutical Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Contract Pharmaceutical Manufacturing.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Contract Pharmaceutical Manufacturing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral
- Injectable
- API
- Other
Applications
- Large Enterprise
- Small Medium Enterprise
Companies covered
- Catalent
- DPx
- Lonza
- Piramal Healthcare
- Aenova
- Jubilant
- Famar
- Boehringer Ingelheim
- Fareva Holding
- AbbVie
- Nipro Corp
- Vetter
- Sopharma
- DPT Laboratories
- Recipharm
- NextPharma
- Dishman
- Aesica
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Contract Pharmaceutical Manufacturing by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Oral
- 2.2.3 Injectable
- 2.2.4 API
- 2.2.5 Other
- 2.3 Contract Pharmaceutical Manufacturing by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Large Enterprise
- 2.3.3 Small Medium Enterprise
- 2.4 Assumptions and Limitations
3 Contract Pharmaceutical Manufacturing Breakdown Data by Type
- 3.1 Global Contract Pharmaceutical Manufacturing Historic Market Size by Type (2021-2026)
- 3.2 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Type (2027-2032)
4 Contract Pharmaceutical Manufacturing Breakdown Data by Application
- 4.1 Global Contract Pharmaceutical Manufacturing Historic Market Size by Application (2021-2026)
- 4.2 Global Contract Pharmaceutical Manufacturing Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Contract Pharmaceutical Manufacturing Market Perspective (2021-2032)
- 5.2 Global Contract Pharmaceutical Manufacturing Growth Trends by Region
- 5.2.1 Global Contract Pharmaceutical Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Contract Pharmaceutical Manufacturing Historic Market Size by Region (2021-2026)
- 5.2.3 Contract Pharmaceutical Manufacturing Forecasted Market Size by Region (2027-2032)
- 5.3 Contract Pharmaceutical Manufacturing Market Dynamics
- 5.3.1 Contract Pharmaceutical Manufacturing Industry Trends
- 5.3.2 Contract Pharmaceutical Manufacturing Market Drivers
- 5.3.3 Contract Pharmaceutical Manufacturing Market Challenges
- 5.3.4 Contract Pharmaceutical Manufacturing Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Contract Pharmaceutical Manufacturing Players by Revenue
- 6.1.1 Global Top Contract Pharmaceutical Manufacturing Players by Revenue (2021-2026)
- 6.1.2 Global Contract Pharmaceutical Manufacturing Revenue Market Share by Players (2021-2026)
- 6.2 Global Contract Pharmaceutical Manufacturing Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Contract Pharmaceutical Manufacturing Head Office and Area Served
- 6.4 Global Contract Pharmaceutical Manufacturing Players, Product Type & Application
- 6.5 Global Contract Pharmaceutical Manufacturing Manufacturers Established Date
- 6.6 Global Contract Pharmaceutical Manufacturing Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Contract Pharmaceutical Manufacturing Market Size (2021-2032)
- 7.2 North America Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
- 7.4 North America Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Contract Pharmaceutical Manufacturing Market Size (2021-2032)
- 8.2 Europe Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
- 8.4 Europe Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size (2021-2032)
- 9.2 Asia-Pacific Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Contract Pharmaceutical Manufacturing Market Size (2021-2032)
- 10.2 South America Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
- 10.4 South America Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size (2021-2032)
- 11.2 Middle East & Africa Contract Pharmaceutical Manufacturing Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Contract Pharmaceutical Manufacturing Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Catalent
- 12.1.1 Catalent Company Information
- 12.1.2 Catalent Business Overview
- 12.1.3 Catalent Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.1.4 Catalent Contract Pharmaceutical Manufacturing Product Portfolio
- 12.1.5 Catalent Recent Developments
- 12.2 DPx
- 12.2.1 DPx Company Information
- 12.2.2 DPx Business Overview
- 12.2.3 DPx Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.2.4 DPx Contract Pharmaceutical Manufacturing Product Portfolio
- 12.2.5 DPx Recent Developments
- 12.3 Lonza
- 12.3.1 Lonza Company Information
- 12.3.2 Lonza Business Overview
- 12.3.3 Lonza Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.3.4 Lonza Contract Pharmaceutical Manufacturing Product Portfolio
- 12.3.5 Lonza Recent Developments
- 12.4 Piramal Healthcare
- 12.4.1 Piramal Healthcare Company Information
- 12.4.2 Piramal Healthcare Business Overview
- 12.4.3 Piramal Healthcare Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.4.4 Piramal Healthcare Contract Pharmaceutical Manufacturing Product Portfolio
- 12.4.5 Piramal Healthcare Recent Developments
- 12.5 Aenova
- 12.5.1 Aenova Company Information
- 12.5.2 Aenova Business Overview
- 12.5.3 Aenova Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.5.4 Aenova Contract Pharmaceutical Manufacturing Product Portfolio
- 12.5.5 Aenova Recent Developments
- 12.6 Jubilant
- 12.6.1 Jubilant Company Information
- 12.6.2 Jubilant Business Overview
- 12.6.3 Jubilant Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.6.4 Jubilant Contract Pharmaceutical Manufacturing Product Portfolio
- 12.6.5 Jubilant Recent Developments
- 12.7 Famar
- 12.7.1 Famar Company Information
- 12.7.2 Famar Business Overview
- 12.7.3 Famar Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.7.4 Famar Contract Pharmaceutical Manufacturing Product Portfolio
- 12.7.5 Famar Recent Developments
- 12.8 Boehringer Ingelheim
- 12.8.1 Boehringer Ingelheim Company Information
- 12.8.2 Boehringer Ingelheim Business Overview
- 12.8.3 Boehringer Ingelheim Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.8.4 Boehringer Ingelheim Contract Pharmaceutical Manufacturing Product Portfolio
- 12.8.5 Boehringer Ingelheim Recent Developments
- 12.9 Fareva Holding
- 12.9.1 Fareva Holding Company Information
- 12.9.2 Fareva Holding Business Overview
- 12.9.3 Fareva Holding Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.9.4 Fareva Holding Contract Pharmaceutical Manufacturing Product Portfolio
- 12.9.5 Fareva Holding Recent Developments
- 12.10 AbbVie
- 12.10.1 AbbVie Company Information
- 12.10.2 AbbVie Business Overview
- 12.10.3 AbbVie Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.10.4 AbbVie Contract Pharmaceutical Manufacturing Product Portfolio
- 12.10.5 AbbVie Recent Developments
- 12.11 Nipro Corp
- 12.11.1 Nipro Corp Company Information
- 12.11.2 Nipro Corp Business Overview
- 12.11.3 Nipro Corp Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.11.4 Nipro Corp Contract Pharmaceutical Manufacturing Product Portfolio
- 12.11.5 Nipro Corp Recent Developments
- 12.12 Vetter
- 12.12.1 Vetter Company Information
- 12.12.2 Vetter Business Overview
- 12.12.3 Vetter Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.12.4 Vetter Contract Pharmaceutical Manufacturing Product Portfolio
- 12.12.5 Vetter Recent Developments
- 12.13 Sopharma
- 12.13.1 Sopharma Company Information
- 12.13.2 Sopharma Business Overview
- 12.13.3 Sopharma Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.13.4 Sopharma Contract Pharmaceutical Manufacturing Product Portfolio
- 12.13.5 Sopharma Recent Developments
- 12.14 DPT Laboratories
- 12.14.1 DPT Laboratories Company Information
- 12.14.2 DPT Laboratories Business Overview
- 12.14.3 DPT Laboratories Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.14.4 DPT Laboratories Contract Pharmaceutical Manufacturing Product Portfolio
- 12.14.5 DPT Laboratories Recent Developments
- 12.15 Recipharm
- 12.15.1 Recipharm Company Information
- 12.15.2 Recipharm Business Overview
- 12.15.3 Recipharm Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.15.4 Recipharm Contract Pharmaceutical Manufacturing Product Portfolio
- 12.15.5 Recipharm Recent Developments
- 12.16 NextPharma
- 12.16.1 NextPharma Company Information
- 12.16.2 NextPharma Business Overview
- 12.16.3 NextPharma Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.16.4 NextPharma Contract Pharmaceutical Manufacturing Product Portfolio
- 12.16.5 NextPharma Recent Developments
- 12.17 Dishman
- 12.17.1 Dishman Company Information
- 12.17.2 Dishman Business Overview
- 12.17.3 Dishman Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.17.4 Dishman Contract Pharmaceutical Manufacturing Product Portfolio
- 12.17.5 Dishman Recent Developments
- 12.18 Aesica
- 12.18.1 Aesica Company Information
- 12.18.2 Aesica Business Overview
- 12.18.3 Aesica Revenue in Contract Pharmaceutical Manufacturing Business (2021-2026)
- 12.18.4 Aesica Contract Pharmaceutical Manufacturing Product Portfolio
- 12.18.5 Aesica Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst